Comerica Bank Has Lowered Starbucks (SBUX) Stake By $802,104, Shorts at Celsion (CLSN) Raised By 1.7%

May 29, 2017 - By Darrin Black

Comerica Bank decreased Starbucks Corp (SBUX) stake by 2.62% reported in 2016Q4 SEC filing. Comerica Bank sold 14,072 shares as Starbucks Corp (SBUX)’s stock rose 6.99%. The Comerica Bank holds 522,198 shares with $30.21M value, down from 536,270 last quarter. Starbucks Corp now has $92.25B valuation. The stock increased 0.64% or $0.4 on May 26, reaching $63.3. About 6.10 million shares traded. Starbucks Corporation (NASDAQ:SBUX) has risen 12.48% since May 29, 2016 and is uptrending. It has underperformed by 4.22% the S&P500.

Celsion Corporation (NASDAQ:CLSN) had an increase of 1.7% in short interest. CLSN’s SI was 5.98M shares in May as released by FINRA. Its up 1.7% from 5.88 million shares previously. With 1.07 million avg volume, 6 days are for Celsion Corporation (NASDAQ:CLSN)’s short sellers to cover CLSN’s short positions. The SI to Celsion Corporation’s float is 14.11%. The stock decreased 93.12% or $3.113 on May 26, reaching $0.23. About 892,806 shares traded. Celsion Corporation (NASDAQ:CLSN) has declined 82.71% since May 29, 2016 and is downtrending. It has underperformed by 99.41% the S&P500.

Analysts await Starbucks Corporation (NASDAQ:SBUX) to report earnings on July, 27 after the close. They expect $0.55 EPS, up 12.24% or $0.06 from last year’s $0.49 per share. SBUX’s profit will be $801.54 million for 28.77 P/E if the $0.55 EPS becomes a reality. After $0.45 actual EPS reported by Starbucks Corporation for the previous quarter, Wall Street now forecasts 22.22% EPS growth.

Among 20 analysts covering Starbucks Corporation (NASDAQ:SBUX), 13 have Buy rating, 0 Sell and 7 Hold. Therefore 65% are positive. Starbucks Corporation had 30 analyst reports since July 28, 2015 according to SRatingsIntel. The company was maintained on Friday, October 30 by RBC Capital Markets. Zacks upgraded the shares of SBUX in report on Monday, August 24 to “Hold” rating. Deutsche Bank downgraded it to “Hold” rating and $64 target in Tuesday, April 12 report. The stock of Starbucks Corporation (NASDAQ:SBUX) has “Strong-Buy” rating given on Friday, August 28 by Vetr. RBC Capital Markets maintained the shares of SBUX in report on Wednesday, October 19 with “Outperform” rating. The firm has “Buy” rating by Goldman Sachs given on Wednesday, May 4. The firm has “Buy” rating given on Wednesday, September 28 by CLSA. The stock of Starbucks Corporation (NASDAQ:SBUX) earned “Outperform” rating by Wedbush on Wednesday, September 28. The rating was maintained by Goldman Sachs on Friday, July 22 with “Buy”. The stock of Starbucks Corporation (NASDAQ:SBUX) has “Buy” rating given on Friday, July 24 by UBS.

Comerica Bank increased Marsh & Mclennan Cos Inc (NYSE:MMC) stake by 14,593 shares to 227,097 valued at $15.38M in 2016Q4. It also upped Procter & Gamble Co (NYSE:PG) stake by 29,003 shares and now owns 889,691 shares. Universal Corp (NYSE:UVV) was raised too.

Since December 8, 2016, it had 0 insider buys, and 8 selling transactions for $32.04 million activity. $9.90 million worth of Starbucks Corporation (NASDAQ:SBUX) was sold by CULVER JOHN. Ramo Joshua Cooper had sold 5,868 shares worth $324,114 on Tuesday, January 31. BURROWS CLIFFORD had sold 80,000 shares worth $4.71M. $1.21 million worth of Starbucks Corporation (NASDAQ:SBUX) was sold by ULLMAN MYRON E III. 113,346 shares valued at $6.15M were sold by BRADLEY WILLIAM W on Thursday, February 2. 29,244 shares valued at $1.72M were sold by Helm Lucy Lee on Wednesday, December 14.

Investors sentiment increased to 1.14 in 2016 Q4. Its up 0.08, from 1.06 in 2016Q3. It improved, as 59 investors sold SBUX shares while 450 reduced holdings. 127 funds opened positions while 452 raised stakes. 970.72 million shares or 1.73% more from 954.23 million shares in 2016Q3 were reported. Smead Cap Mngmt Incorporated accumulated 390,916 shares or 1.1% of the stock. One Cap Mngmt Limited Liability reported 8,758 shares. Bluecrest Capital Ltd invested in 0.06% or 20,000 shares. Douglass Winthrop Ltd Llc, a New York-based fund reported 22,329 shares. The New York-based Cipher Capital Limited Partnership has invested 0.21% in Starbucks Corporation (NASDAQ:SBUX). Aspiriant Limited Liability Corp, California-based fund reported 8,542 shares. Wagner Bowman Management Corp owns 0.54% invested in Starbucks Corporation (NASDAQ:SBUX) for 29,200 shares. The California-based Tarbox Gru has invested 0.01% in Starbucks Corporation (NASDAQ:SBUX). Jacobs Ca, California-based fund reported 151,691 shares. Shell Asset Mngmt Comm reported 162,943 shares. Mitsubishi Ufj Bk Corp accumulated 3.08 million shares. Salient Comm Lta invested 0.47% of its portfolio in Starbucks Corporation (NASDAQ:SBUX). Goelzer Invest Management stated it has 0.26% in Starbucks Corporation (NASDAQ:SBUX). Private Wealth Prtn holds 0.62% in Starbucks Corporation (NASDAQ:SBUX) or 46,840 shares. Cim Invest Mangement owns 36,071 shares.

Investors sentiment increased to 1.22 in Q4 2016. Its up 0.40, from 0.82 in 2016Q3. It improved, as 9 investors sold Celsion Corporation shares while 0 reduced holdings. 3 funds opened positions while 8 raised stakes. 4.88 million shares or 46.85% more from 3.32 million shares in 2016Q3 were reported. Carroll Fincl Assocs Inc invested 0% of its portfolio in Celsion Corporation (NASDAQ:CLSN). Sabby Mngmt Ltd Llc reported 1.33 million shares. First Manhattan stated it has 0% in Celsion Corporation (NASDAQ:CLSN). Blackrock Inv Management Ltd Liability Co stated it has 3,825 shares. Blackrock Institutional Com Na owns 982,475 shares. Kcg owns 150,626 shares for 0% of their portfolio. Fincl Bank Of Ny Mellon Corp invested in 0% or 25,169 shares. Blackrock has invested 0% in Celsion Corporation (NASDAQ:CLSN). Barclays Public Limited Com owns 0% invested in Celsion Corporation (NASDAQ:CLSN) for 70 shares. Moreover, California Public Employees Retirement Sys has 0% invested in Celsion Corporation (NASDAQ:CLSN) for 67,122 shares. Vanguard Group Inc Inc holds 575,889 shares. Wells Fargo And Co Mn holds 0% of its portfolio in Celsion Corporation (NASDAQ:CLSN) for 1,500 shares. Citadel Ltd Liability Company has 67,522 shares for 0% of their portfolio. Moreover, Gp One Trading Limited Partnership has 0% invested in Celsion Corporation (NASDAQ:CLSN). Renaissance Techs Ltd Limited Liability Company has invested 0% in Celsion Corporation (NASDAQ:CLSN).

Celsion Corporation is an oncology drug development company. The company has market cap of $12.62 million. The Company’s product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer and a Phase II clinical trial for treatment of recurrent chest wall breast cancer (the DIGNITY Study). It currently has negative earnings. The Company’s pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers.